Bentham
Science Publishers, a renowned publisher that publishes 116
print and online journals, associated print/online book series and 150 plus
open access journals. Bentham Science Publishers serves the needs of scientists,
doctors, scholars and researchers in the fields of engineering, pharmaceutical,
medical, biomedical, medical, technology, social sciences and computers. One of
its leading journals include Current Gene Therapy (Impact Factor 5.318), which
is indexed in Biotechnology Citation
Index®, Science Citation Index Expanded™, and Index to
Scientific Reviews®, Current Contents® /Life Sciences, Journal Citation
Reports/Science Edition and many more. In this Journal, the recent gene
therapy trends are discussed.
The drug developers and researchers are
working hard to find out new ways of eliminating infection and illnesses. The
most recent discovery for the treatment of various conditions is gene therapy.
This is a sort of treatment in which a healthy gene is introduced into the
patient’s tissues and cell, and replaces it with the lethal mutant allele. The
outcome of this therapy is promising; however there is always a room for
expansion and improvement.
A recent study of the researcher in
Italy suggests that if a mutated gene is transmitted into a children body, who
is suffering from Wiskott - Aldrich syndrome, Metachromatic Leukodystrophy can
be cured effectively by replacing the effected gene from healthy gene. The
development of a child is affected if he is suffering from Metachromatic
Leukodystrophy. However, Wiskott - Aldrich syndrome leads to a weaker immune
system in kids.
The success of the gene therapy, assures
that the other diseases can be treated in the same manner to achieve better
results.
No comments:
Post a Comment